Zepp Health Corporation (NYSE: ZEPP) Stock Competitors & Peer Comparison

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, AAPL has a market cap of 4.5T. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while AAPL trades at $309.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas AAPL's P/E ratio is 35.44. In terms of profitability, ZEPP's ROE is -0.24%, compared to AAPL's ROE of +1.37%. Regarding short-term risk, ZEPP is more volatile compared to AAPL. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check AAPL's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, SONY has a market cap of 140.5B. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while SONY trades at $23.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas SONY's P/E ratio is 20.43. In terms of profitability, ZEPP's ROE is -0.24%, compared to SONY's ROE of -0.03%. Regarding short-term risk, ZEPP is more volatile compared to SONY. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check SONY's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, LPL has a market cap of 3.3B. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while LPL trades at $3.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas LPL's P/E ratio is -3.60. In terms of profitability, ZEPP's ROE is -0.24%, compared to LPL's ROE of -0.21%. Regarding short-term risk, ZEPP is more volatile compared to LPL. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check LPL's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, BWSN has a market cap of 2.8B. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while BWSN trades at $25.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas BWSN's P/E ratio is N/A. In terms of profitability, ZEPP's ROE is -0.24%, compared to BWSN's ROE of +0.78%. Regarding short-term risk, ZEPP is more volatile compared to BWSN. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check BWSN's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, VZIO has a market cap of 2.3B. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while VZIO trades at $11.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas VZIO's P/E ratio is 162.14. In terms of profitability, ZEPP's ROE is -0.24%, compared to VZIO's ROE of +0.07%. Regarding short-term risk, ZEPP is more volatile compared to VZIO. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check VZIO's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, SONO has a market cap of 1.9B. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while SONO trades at $15.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas SONO's P/E ratio is 22.61. In terms of profitability, ZEPP's ROE is -0.24%, compared to SONO's ROE of -0.10%. Regarding short-term risk, ZEPP is more volatile compared to SONO. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check SONO's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, HEAR has a market cap of 357.4M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while HEAR trades at $17.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas HEAR's P/E ratio is 57.42. In terms of profitability, ZEPP's ROE is -0.24%, compared to HEAR's ROE of -0.03%. Regarding short-term risk, ZEPP is more volatile compared to HEAR. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check HEAR's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, TBCH has a market cap of 251.3M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while TBCH trades at $12.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas TBCH's P/E ratio is 253.20. In terms of profitability, ZEPP's ROE is -0.24%, compared to TBCH's ROE of -0.03%. Regarding short-term risk, ZEPP is less volatile compared to TBCH. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check TBCH's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, VUZI has a market cap of 244.5M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while VUZI trades at $2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas VUZI's P/E ratio is -7.35. In terms of profitability, ZEPP's ROE is -0.24%, compared to VUZI's ROE of -0.89%. Regarding short-term risk, ZEPP is less volatile compared to VUZI. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check VUZI's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, VOXX has a market cap of 169M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while VOXX trades at $7.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas VOXX's P/E ratio is -2.43. In terms of profitability, ZEPP's ROE is -0.24%, compared to VOXX's ROE of -0.13%. Regarding short-term risk, ZEPP is more volatile compared to VOXX. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check VOXX's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, GPRO has a market cap of 107.8M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while GPRO trades at $0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas GPRO's P/E ratio is -1.17. In terms of profitability, ZEPP's ROE is -0.24%, compared to GPRO's ROE of -5.30%. Regarding short-term risk, ZEPP is less volatile compared to GPRO. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check GPRO's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, UEIC has a market cap of 61.3M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while UEIC trades at $4.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas UEIC's P/E ratio is 14.70. In terms of profitability, ZEPP's ROE is -0.24%, compared to UEIC's ROE of -0.11%. Regarding short-term risk, ZEPP is less volatile compared to UEIC. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check UEIC's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, KOSS has a market cap of 33.8M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while KOSS trades at $3.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas KOSS's P/E ratio is -32.45. In terms of profitability, ZEPP's ROE is -0.24%, compared to KOSS's ROE of -0.04%. Regarding short-term risk, ZEPP is more volatile compared to KOSS. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check KOSS's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, FOXX has a market cap of 20.5M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while FOXX trades at $2.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas FOXX's P/E ratio is -0.92. In terms of profitability, ZEPP's ROE is -0.24%, compared to FOXX's ROE of +2.61%. Regarding short-term risk, ZEPP is less volatile compared to FOXX. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check FOXX's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, MSN has a market cap of 8.7M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while MSN trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas MSN's P/E ratio is -2.17. In terms of profitability, ZEPP's ROE is -0.24%, compared to MSN's ROE of -0.20%. Regarding short-term risk, ZEPP is less volatile compared to MSN. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check MSN's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, PXDT has a market cap of 8.6M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while PXDT trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas PXDT's P/E ratio is -0.65. In terms of profitability, ZEPP's ROE is -0.24%, compared to PXDT's ROE of -1.19%. Regarding short-term risk, ZEPP is more volatile compared to PXDT. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check PXDT's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, FEBO has a market cap of 7.9M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while FEBO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas FEBO's P/E ratio is -0.06. In terms of profitability, ZEPP's ROE is -0.24%, compared to FEBO's ROE of -0.41%. Regarding short-term risk, ZEPP is less volatile compared to FEBO. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check FEBO's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, MICS has a market cap of 7.2M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while MICS trades at $0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas MICS's P/E ratio is -0.50. In terms of profitability, ZEPP's ROE is -0.24%, compared to MICS's ROE of +0.83%. Regarding short-term risk, ZEPP is less volatile compared to MICS. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check MICS's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, UTME has a market cap of 6.3M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while UTME trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas UTME's P/E ratio is -0.42. In terms of profitability, ZEPP's ROE is -0.24%, compared to UTME's ROE of -1.61%. Regarding short-term risk, ZEPP is less volatile compared to UTME. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check UTME's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, BOXL has a market cap of 3.8M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while BOXL trades at $5.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas BOXL's P/E ratio is -0.16. In terms of profitability, ZEPP's ROE is -0.24%, compared to BOXL's ROE of -12.74%. Regarding short-term risk, ZEPP is less volatile compared to BOXL. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check BOXL's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, WLDSW has a market cap of 1.7M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while WLDSW trades at $6.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas WLDSW's P/E ratio is N/A. In terms of profitability, ZEPP's ROE is -0.24%, compared to WLDSW's ROE of -0.72%. Regarding short-term risk, ZEPP is more volatile compared to WLDSW. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check WLDSW's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, WTO has a market cap of 1.4M. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while WTO trades at $7.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas WTO's P/E ratio is -0.00. In terms of profitability, ZEPP's ROE is -0.24%, compared to WTO's ROE of -14.75%. Regarding short-term risk, ZEPP is less volatile compared to WTO. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check WTO's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, RIME has a market cap of 852.5K. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while RIME trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas RIME's P/E ratio is -0.14. In terms of profitability, ZEPP's ROE is -0.24%, compared to RIME's ROE of -6.36%. Regarding short-term risk, ZEPP is less volatile compared to RIME. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check RIME's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, EVLVW has a market cap of 724.4K. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while EVLVW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas EVLVW's P/E ratio is -0.01. In terms of profitability, ZEPP's ROE is -0.24%, compared to EVLVW's ROE of -0.05%. Regarding short-term risk, ZEPP is more volatile compared to EVLVW. This indicates higher risk in terms of short-term price fluctuations for ZEPP.Check EVLVW's competition here

Zepp Health Corporation (NYSE: ZEPP) plays a significant role within the Technology sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZEPP stands at 74.3M. In comparison, WLDS has a market cap of 259.1K. Regarding current trading prices, ZEPP is priced at $5.15 on the NYSE, while WLDS trades at $2.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZEPP currently has a P/E ratio of -2.65, whereas WLDS's P/E ratio is -0.06. In terms of profitability, ZEPP's ROE is -0.24%, compared to WLDS's ROE of -0.72%. Regarding short-term risk, ZEPP is less volatile compared to WLDS. This indicates lower risk in terms of short-term price fluctuations for ZEPP.Check WLDS's competition here